GS Investments’s Psychemedics Corporation PMD Stock Holding History

GS Investments’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,000	Closed	-$46K	–	130
2020 Q4	$46K	Buy	+9,000	New	+$39.1K	0.04%	88
2020 Q3	–	Sell	-9,000	Closed	-$49.5K	–	118
2020 Q2	$49.5K	Sell	9,000 -5,000	-36%	-$27.9K	0.04%	79
2020 Q1	$84.7K	Sell	14,000 -1,800	-11%	-$15.2K	0.08%	69
2019 Q4	$304K	Buy	15,800 +500	+3%	+$4.62K	0.25%	62
2019 Q3	$139K	Hold	15,300	–	–	0.1%	71
2019 Q2	$154K	Hold	15,300	–	–	0.13%	73
2019 Q1	$215K	Sell	15,300 -500	-3%	-$8.6K	0.17%	71
2018 Q4	$251K	Hold	15,800	–	–	0.21%	65
2018 Q3	$297K	Hold	15,800	–	–	0.21%	67
2018 Q2	$304K	Hold	15,800	–	–	0.23%	66
2018 Q1	$337K	Buy	15,800 +300	+2%	+$6.23K	0.25%	63
2017 Q4	$319K	Hold	15,500	–	–	0.24%	64
2017 Q3	$286K	Hold	15,500	–	–	0.23%	69
2017 Q2	$387K	Buy	+15,500	New	+$326K	0.29%	63

Other funds holding PMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GS Investments's PMD Position: Q1 2021 in Review

GS Investments sold out of Psychemedics Corporation (PMD) in Q1 2021, closing a stake of 9,000 shares — an estimated $46K sold.

GS Investments first reported a position in PMD in Q2 2017 and held it in 14 quarters. The position peaked at $387K in Q2 2017. 31 funds tracked by Wall St. Rank hold PMD as of Q1 2021.

GS Investments reported no remaining Psychemedics Corporation position as of Q1 2021 after selling out during the quarter.
GS Investments sold 9,000 Psychemedics Corporation shares in Q1 2021, an estimated $46K.
GS Investments first reported a position in Psychemedics Corporation in Q2 2017 and held it in 14 quarters.
GS Investments's Psychemedics Corporation position peaked at $387K in Q2 2017.
31 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2021.

Based on GS Investments's 13F filing for Q1 2021, filed 7 May 2021.